Gsk (GSK) Shares Outstanding (2017 - 2025)

Gsk (GSK) has 9 years of Shares Outstanding data on file, last reported at $5.7 billion in Q4 2025.

• In Q4 2025, Shares Outstanding rose 3.66% year-over-year to $5.7 billion; the TTM figure through Dec 2025 stood at $5.7 billion (up 3.66% YoY), while the FY2025 annual figure was $5.7 billion, up 3.66% from the prior year.
• Shares Outstanding advanced to $5.7 billion in Q4 2025, from $5.5 billion in the prior quarter.
• Across five years, Shares Outstanding topped out at $7.3 billion in Q4 2021 and bottomed at $5.1 billion in Q4 2022.
• A 5-year average of $5.8 billion and a median of $5.5 billion in 2024 frame the typical range for Shares Outstanding.
• Annual changes were most pronounced in 2022 — Shares Outstanding plunged 30.36% — and 2023, when it advanced 5.84%.
• Year by year, Shares Outstanding stood at $7.3 billion in 2021, then tumbled by 30.36% to $5.1 billion in 2022, then gained by 5.84% to $5.4 billion in 2023, then rose by 3.46% to $5.5 billion in 2024, then increased by 3.66% to $5.7 billion in 2025.
• The last three Shares Outstanding figures came in at $5.7 billion (Q4 2025), $5.5 billion (Q4 2024), and $5.4 billion (Q4 2023), per Business Quant data.

Peer Comparison